Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_assertion type Assertion NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_head.
- NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_assertion wasGeneratedBy ECO_0000203 NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_provenance.
- NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_assertion wasDerivedFrom befree-2016 NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_provenance.
- NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_assertion SIO_000772 22279054 NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_provenance.
- NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_assertion evidence source_evidence_literature NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_provenance.
- NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_assertion description "[The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956172.RA-ykiovFoTJlUxqT55zQBsibu2YvXdM_Qgoby0FVF4EQ130_provenance.